Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

News

September 8, 2011 – A randomized multicenter, open-label study evaluating the efficacy and safety of prolonged ...

Home September 08, 2011
Home
Feature

September 8, 2011 – Patients at a high risk for a second stroke who received intensive medical treatment had fewer ...

Home September 08, 2011
Home
News

September 6, 2011 — The European Society of Cardiology (ESC) released the latest version of its guidelines for managing ...

Home September 06, 2011
Home
News

August 30, 2011 – Compared with patients who had persistently high platelet reactivity, those who achieved low platelet ...

Home August 30, 2011
Home
Feature

August 18, 2011 — The antiplatelet agent prasugrel (trade name Effient), in combination with aspirin, was associated ...

Home August 19, 2011
Home
News

Aug. 2, 2011 — New York University (NYU) Langone Medical Center received an $84 million grant from the National Heart ...

Home August 02, 2011
Home
Technology

July 21, 2011 – The U.S. Food and Drug Administration (FDA) today approved AstraZeneca’s blood-thinning drug ticagrelor ...

Home July 21, 2011
Home
News

July 5, 2011 — Janssen Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) has approved ...

Home July 05, 2011
Home
News

Home June 30, 2011
Home
News

June 14, 2011 – New performance measures for adults with coronary artery disease (CAD) and hypertension were released ...

Home June 14, 2011
Home
News

June 10, 2011 – The U.S. Food and Drug Administration (FDA) announced safety label changes for the cholesterol-lowering ...

Home June 10, 2011
Home
News

June 3, 2011 – European CE mark approval was granted to expand use of the VerifyNow point-of-care P2Y12 test platelet ...

Home June 03, 2011
Home
News

April 22, 2011 – A new study found that coronary artery bypass surgery added to medical therapy for selected ...

Home April 22, 2011
Home
Technology

April 21, 2011 – A new angiotensin II receptor blocker (ARB) has been approved by the U.S. Food and Drug ...

Home April 21, 2011
Home
News

April 21, 2011 – Baxter International has entered into a definitive agreement to acquire privately-held Prism ...

Home April 21, 2011
Home
Subscribe Now